Hematologic Malignancies Members
Monzr M. Al Malki, M.D., is an associate professor in the Department of Hematology & Hematopoietic Cell Transplantation and is board certified in internal medicine, hematology and medical oncology at City of Hope.
Ibrahim T. Aldoss, M.D., is a hematologist-oncologist and board certified in internal medicine, medical oncology and hematology. His clinical expertise is in acute lymphoblastic leukemia and acute myeloid leukemia.
Brian Ball, M.D., is a hematologist-oncologist in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope.
Pamela Becker, M.D., Ph.D., is a highly respected clinician with expertise in acute myeloid leukemia, multiple myeloma, bone marrow failure & other diseases of the blood & immune system.
Elizabeth Budde, M.D., Ph.D., is an oncologist and associate professor at City of Hope.
Modulation of the bone marrow niche to redirect cellular networks in stress and malignant hematopoiesis
John Chan, M.D., is a hemapathologist and co-leader of the hematology malignancies program at City of Hope Cancer Center.
Sanjeet Singh Dadwal, M.D., is chief, Division of Infectious Diseases, and professor in the Department of Medicine, with a clinical focus on infectious diseases.
Alexey Danilov, M.D., Ph.D., is the associate director of the Toni Stephenson Lymphoma Center and professor in the Department of Hematology & Hematopoietic Cell Transplantation.
Stephen J. Forman, M.D., hematologist-oncologist, is a top cancer doctor for leukemia, lymphoma & bone marrow transplantation. He is also the director of the Hematologic Malignancies Research Institute & director of the T Cell Therapeutics Research Laboratory at City of Hope, Duarte, California.
James Godfrey, M.D., is an hematologist and assistant professor in the Department of Hematology & Hematopoietic Cell Transplantation Department at City of Hope in Duarte, California.
Dr. Gu’s research focus is to integrate multi-omics platforms, advanced analytical approaches, and multiple experimental models to study the heterogeneity of acute leukemias and facilitate the development of more efficacious targeted therapies.
Alex Herrera, M.D., is a hematologist-oncologist at City of Hope who specializes in treating and researching lymphoma.
Susanta Hui, Ph.D., is a Clinical Professor, Department of Radiation Oncology at City of Hope in Duarte, CA.
Amrita Krishnan, M.D., directs the Judy and Bernard Briskin Center for Multiple Myeloma Research at City of Hope's cancer research hospital, seeking to make gains in one of the most rapidly changing areas in cancer research.
Ya-Huei Kuo, Ph.D. is an associate professor in the Department of Hematologic Malignancies Translational Science with a research focus in leukemia biology.
Larry Kwak, M.D., Ph.D., is the director of the Toni Stephenson Lymphoma Center at City of Hope.
Ling Li, Ph.D., is an associate professor in Beckman Research Institute's Department of Hematologic Malignancies Translational Science.
Guido Marcucci, M.D., is professor and chair of the Department of Hematological Malignancies Translational Science and chief of the Division of Leukemia.
Ryotaro Nakamura, M.D., is the Jan & Mace Siegel Professor in Hematology & Hematopoietic Cell Transplantation professor and a hematologist/oncologist at City of Hope.
Vu Nguyen Ngo, Ph.D., is an associate professor in the Department of Systems Biology at Beckman Research Institute of City of Hope.
Dr. Palmer’s research interests and effort support preclinical and clinical studies concerning the major obstacles to disease control/cure of hematologic malignancies and successful hematopoietic stem cell transplantation.
Anna Pawlowska, M.D., specializes in treating young people with leukemia and directs our Pediatric Hematopoietic Cell Transplantation Program.
Tycel Phillips, M.D., is a hematologist-oncologist in the Division of Lymphoma, Department of Hematology & Hematopoietic Cell Transplantation, at City of Hope in Duarte, CA.
Flavia Pichiorri, Ph.D., M.S., is a professor in the Department of Hematologic Malignancies Translational Science.
Leslie Popplewell, M.D., is a hematologist specializing in lymphoma at City of Hope near Los Angeles.
Christiane Querfeld, M.D., Ph.D., is a dermatologist and dermatopathologist who specializes in the diagnosis and treatment of cutaneous lymphoma.
Steven T. Rosen, M.D., provost and chief scientific officer, and director of the comprehensive cancer center and Beckman Research Institute of City of Hope, sets the scientific direction of City of Hope, shaping its vision as a cancer research, treatment and educational institution.
Michael Rosenzweig, M.D., is Chief, Division of Multiple Myeloma and a hematologist-oncologist, in the Department of Hematology & Hematopoietic Cell Transplantation at City of Hope in Duarte, CA.
Tanya Siddiqi, M.D., is a hematologist specializing in leukemia, lymphoma and hematopoietic cell transplantation.
Eileen P. Smith, M.D., chair of the Department of Hematology & Hematopoietic Cell Transplantation, leads City of Hope with her expertise in hematology and oncology.
Joo Song, M.D., is an associate clinical professor and chief of the Division of Hematopathology at City of Hope.
Anthony Stein, M.D., is a hematologist-oncologist who specializes in treating and researching acute myeloid leukemia.
Srividya Swaminathan, Ph.D., is an assistant professor in the Department of Systems Biology.
Lili Wang, M.D., Ph.D., is an associate professor in the Department of Systems Biology.
